Biomarkers of susceptibility to type 1 diabetes with special reference to the Indian population

Indian Journal of Medical Research

Volumn 125, Issue 3, 2007, Pages 321-344

  Mehra, Narinder K ^a   Kumar, Neeraj ^a   Kaur, Gurvinder ^a   Kanga, Uma ^a   Tandon, Nikhil ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Autoimmunity; CTLA4; Haplotypes; HLA; Insulin; MHC; Type 1 diabetes

Indexed keywords

BIOLOGICAL MARKER; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GLUTAMATE DECARBOXYLASE ANTIBODY; HLA A ANTIGEN; HLA A1 ANTIGEN; HLA A24 ANTIGEN; HLA A26 ANTIGEN; HLA A3 ANTIGEN; HLA A31 ANTIGEN; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; HLA B8 ANTIGEN; HLA DR3 ANTIGEN; INSULIN; INSULINOMA ASSOCIATED PROTEIN 2 AUTOANTIBODY; ISLET CELL AUTANTIGEN 69; PANCREAS ISLET CELL ANTIBODY; UNCLASSIFIED DRUG;

ALLELE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CAUCASIAN; CELLULAR IMMUNITY; GENE LOCUS; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETIC VARIABILITY; HAPLOTYPE; HIGH RISK PATIENT; HUMAN; HUMAN GENOME; HUMORAL IMMUNITY; IMMUNE RESPONSE; INDIA; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR HISTOCOMPATIBILITY COMPLEX; PATHOGENESIS; REVIEW; RISK FACTOR; SURVIVAL;

ANTIGENS, CD; ANTIGENS, DIFFERENTIATION; AUTOANTIBODIES; AUTOIMMUNITY; CHROMOSOME MAPPING; CONTINENTAL POPULATION GROUPS; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IMMUNITY, CELLULAR; INDIA;

EID: 34249328873     PISSN: 09715916     EISSN: 09715916     Source Type: Journal    
DOI: None     Document Type: Review

References (125)

1. Zimmet P, Alberti KGMM, Shaw J. Global and societal implications of the diabetes epidemic. Nature 2001; 414: 782-7.
2. Onkamo P, Vaananen S, Karvonen M, Tuomilehto J. Worldwide increase in incidence of type 1 diabetes - the analysis of the data on published incidence trends. Diabetologia 1999; 42: 1395-403.
3. Karvonen M, Viik-Kajander M, Moltchanova E, Libman I, LaPorte R, Tuomilehto J. Incidence of childhood type 1 diabetes worldwide. Diabetes Care 2000; 23: 1516-26.
4. Ramachandran A, Snehalatha C, Krishnaswami CV. Incidence of IDDM in urban population in southern India. Madras IDDM Registry Group Madras, South India. Diabetes Res Clin Pract 1996; 34: 79-82.
5. Yu L, Robles DT, Abiru N, Kaur P, Rewers M, Kelemen K, et al. Early expression of anti-insulin autoantibodies of human and the NOD mouse: evidence for early determination of subsequent diabetes. Proc Natl Acad Sci USA 2000; 97: 1701-6.
6. Hagopian WA, Michelsen B, Karlsen AE, Larsen F, Moddy A, Grubin CE, et al. Autoantibodies in IDDM primarily recognize the 65,000-M(r) isoform of glutamic acid than the 67,000M(r) isoform of glutamic acid decarboxylase. Diabetes 1993; 42: 631-6.
7. Goswami R, Kochupillai N, Gupta N, Kukreja A, Lan M, Maclaren NK. Islet cell autoimmunity in youth onset diabetes mellitus in Northern India. Diab Res Clin Pract 2001; 53: 47-54.
8. Tandon N, Shtauvere-Brameus A, Hagopian WA, Sanjeevi CB. Prevalence of ICA-12 and other autoantibodies in north Indian patients with early-onset diabetes. Ann NY Acad Sci 2002; 958: 214-7.
9. Abraham RS, Kudva YC, Wilson SB, Strominger JL, David CS. Co-expression of HLA-DR3 and DQ8 results in the development of spontaneous insulitis and loss of tolerance to GAD65 in transgenic mice. Diabetes 2000; 49: 548-54.
10. Palmer JP, Asplin CM, Clemons P, Lyen K, Tatpati O, Raghu PK, et al. Insulin antibodies in insulin-dependent diabetics before insulin treatment. Science 1983; 222: 1337-9.
11. Kuglin B, Gries FA, Kolb H. Evidence of IgG autoantibodies against human proinsulin in patients with IDDM before insulin treatment. Diabetes 1988; 37: 130-2.
12. Padoa CJ, Banga JP, Madec AM, Ziegler M, Schlosser M, Ortqvist E, et al. Recombinant Fabs of human monoclonal antibodies specific to the middle epitope of GAD65 inhibit type 1 diabetes-specific GAD65Abs. Diabetes 2003; 52: 2689-95.
13. Roep BO, Duinkerken G, Schreuder GM, Kolb H, de Vries RR, Martin S. HLA-associated inverse correlation between T cell and antibody responsiveness to islet autoantigen in recent-onset insulin-dependent diabetes mellitus. Eur J Immunol 1996; 26: 1285-9.
14. Lan MS, Wasserfall C, Maclaren NK, Notkins AL. IA-2, a transmembrane protein of the protein tyrosine phosphatase family, is a major autoantigen in insulin-dependent diabetes mellitus. Proc Natl Acad Sci USA 1996; 93: 6367-70.
15. Lampasona V, Bearzarro M, Genovese S, Bosi E, Ferrari M, Bonifacio E. Autoantibodies in insulin-dependent diabetes recognize distinct cytoplasmic domains of the protein tyrosine phosphatase-like IA-2 autoantigen. J Immunol 1996; 157: 2707-11.
16. Horvath L, Cervenak L, Oroszlan M, Prohaszka Z, Uray K, Hudecz F, et al. Antibodies against different epitopes of heat-shock protein 60 in children with type 1 diabetes mellitus. Immunol Lett 2002; 80: 155-62.
17. Abulafia-Lapid R, Gillis D, Yosef O, Atlan H, Cohen IR. T cells and autoantibodies to human HSP70 in Type 1 diabetes in children. J Autoimmun 2003; 20: 313-21.
18. Qin HY, Mahon JL, Atkinson MA, Chaturvedi P, Lee-Chan E, Singh B. Type 1 diabetes alters anti-hsp90 autoantibody isotype. J Autoimmun 2003; 20: 237-45.
19. Castano L, Russo E, Zhou L, Lipes MA, Eisenbarth GS. Identification and cloning of a granule autoantigen (carboxypeptidase-H) associated with type I diabetes. J Clin Endocrinol Metab 1991; 73: 1197-201.
20. Roep BO. The role of T-cells in the pathogenesis of Type 1 diabetes: From cause to cure. Diabetologia 2003; 46: 305-21.
21. Reijonen H, Novak EJ, Kochik S, Heninger A, Liu AW, Kwok WW, et al. Detection of GAD65-specific T-cells by major histocompatibility complex class II tetramers in type 1 diabetic patients and at-risk subjects. Diabetes 2002; 51: 1375-82.
22. Nepom GT, Lippolis JD, White FM, Masewicz S, Matro JA, Herman A, et al. Identification and modulation of a naturally processed T cell epitope from the diabetes-associated autoantigen human glutamic acid decarboxylase 65 (hGAD65). Proc Natl Acad Sci USA 2001; 98: 1763-8.
23. Kaufman DL, Clare-Salzler M, Tian J, Forsthuber T, Ting GS, Robinson P, et al. Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes. Nature 1993; 366: 69-72.
24. Durinovic-Bello I, Hummel M, Ziegler AG. Cellular immune response to diverse islet cell antigens in IDDM. Diabetes 1996; 45: 795-800.
25. Abulafia-Lapid R, Elias D, Raz I, Keren-Zur Y, Atlan H, Cohen IR, et al. T cell proliferative responses of type 1 diabetes patients and healthy individuals to human hsp60 and its peptides. J Autoimmun 1999; 12: 121-9.
26. Karges W, Hammond-McKibben D, Gaedigk R, Shibuya N, Cheung R, Dosch HM. Loss of self-tolerance to ICA69 in nonobese diabetic mice. Diabetes 1997; 46: 1548-56.
27. Martinez NR, Augstein P, Moustakas AK, Augstein P, Moustakas AK, Papadopoulos GK, et al. Disabling an integral CTL epitope allows suppression of autoimmune diabetes by intranasal proinsulin peptide. J Clin Invest 2003; 111: 1365-71.
28. Wong FS, Karttunen J, Dumont C, Wen L, Visintin I, Philip IM, et al. Identification of an MHC class I-restricted autoantigen in type 1 diabetes by screening an organspecific cDNA library. Nat Med 1999; 5: 1026-31.
29. Panagiotopoulos C, Qin H, Tan R, Verchere CB. Identification of a beta-cell specific MHC class I restricted epitope in type 1 diabetes. Diabetes 2003; 52: A46.
30. Panina-Bordignon P, Lang R, van Endert PM, Benazzi E, Felix AM, Pastore RM, et al. Cytotoxic T cells specific for glutamic acid decarboxylase in autoimmune diabetes. J Exp Med 1995; 181: 1923-7.
31. + T cells in autoimmune diabetes. Proc Natl Acad Sci USA 2003; 100: 8384-8.
32. Lo SS, Tun RY, Hawa M, Leslie RD. Studies of diabetic twins. Diabetes 1991; 7: 233-8.
33. Cox NJ, Wapelhorst B, Morrison VA, Johnson L, Pinchuk L, Spielman RS, et al. Seven regions of the genome show evidence of linkage to type 1 diabetes in a consensus analysis of 767 multiplex families. Am J Hum Genet 2001; 69: 820-30.
34. Pugliese A, Eisenbarth GS. Type 1 diabetes mellitus of man: genetic susceptibility and resistance. Adv Exp Med Biol 2004; 552: 170-203.
35. She JX, Marron MP. Genetic susceptibility factors in type 1 diabetes: linkage disequilibrium and functional analyses. Curr Opin Immunol 1998; 10: 682-9.
36. Bell GI, Horita S, Karam JH. A polymorphic locus near the human insulin gene is associated with insulin-dependent diabetes mellitus. Diabetes 1984; 33: 176-83.
37. Thorsby E. Invited anniversary review: HLA associated diseases. Hum Immunol 1997; 53: 1-11.
38. Shiina T, Tamiya G, Oka A, Takishima N, Inoko H. Genome sequencing analysis of the 1.8 Mb entire human MHC class I region. Immunol Rev 1999; 167: 193-9.
39. Mehra NK, Kaur G, Kanga U, Tandon N. Immunogenetics of autoimmune diseases in Asian Indians. Ann NY Acad Sci 2002; 958: 333-6.
40. Witt CS, Price P, Kaur G, Cheong K, Kanga U, Sayer D, et al. The common HLA-B8-DR3 haplotype in northern India is different from that found in Europe. Tissue Antigens 2002; 60: 474-80.
41. Kanga U, Vaidyanathan B, Jaini R, Menon PS, Mehra NK. HLA haplotypes associated with type 1 diabetes mellitus in North Indian children. Hum Immunol 2004; 65: 47-53.
42. Rani R, Sood A, Lazaro A, Stastny P. Associations of MHC class II alleles with insulin dependent diabetes mellitus (IDDM) in patients from North India. Hum Immunol 1999; 60: 524-31.
43. Rani R, Sood A, Goswami R. Molecular basis of predisposition to develop type 1 diabetes mellitus in North Indians. Tissue Antigens 2004; 64: 145-55.
44. Field LL. Genetic linkage and association studies of type 1 diabetes: challenges and rewards. Diabetologia 2002; 45: 21-35.
45. Erlich HA, Rotter JI, Chang JD, Shaw SJ, Raffel LJ, Klitz W, et al. Association of HLA-DPBI*0301 with IDDM in Mexican-Americans. Diabetes 1996; 45: 610-4.
46. Noble JA, Valdes AM, Thomson G, Erlich HA. The HLA class II locus DPB1 can influence susceptibility to type 1 diabetes. Diabetes 2000; 49: 121-5.
47. Cucca F, Dudbridge F, Loddo M, Mulargia AP, Lampis R, Angius E, et al. The HLA-DPB1 - associated component of the IDDM1 and its relationship to the major loci HLADQB1-DQA1, and - DRB1. Diabetes 2001; 50: 1200-5.
48. Begovich AB, McClure GR, Suraj VC, Helmuth RC, Flides N, Bugawan TL, et al. Polymorphism, recombination, and linkage disequilibrium within the HLA class II region. J Immunol 1992; 148: 249-58.
49. Kaur G, Sarkar N, Bhatnagar S, Kumar S, Rapthap CC, Bhan MK, et al. Pediatric celiac disease in India is associated with multiple DR3-DQ2 haplotypes. Hum Immunol 2002; 63: 677-82.
50. Abraham RS, Wen L, Marietta EV, David CS. Type 1 diabetes-predisposing MHC alleles influence the selection of glutamic acid decarboxylase (GAD) 65-specific T cells in a transgenic model. J Immunol 2001; 166: 1370-9.
51. Wen L, Chen NY, Tang J, Sherwin R, Wong FS. The regulatory role of DR4 in a spontaneous diabetes DQ8 transgenic model. J Clin Invest 2001; 107: 871-80.
52. Cucca F, Lampis R, Congia M, Angius E, Nutland S, Bain SC, et al. A correlation between the relative predisposition of MHC class II alleles to type 1 diabetes and the structure of their proteins. Hum Mol Genet 2001; 10: 2025-37.
53. Lee KH, Wucherpfennig KW, Wiley DC. Structure of a human insulin peptide-HLA-DQ8 complex and susceptibility to type 1 diabetes. Nat Immunol 2001; 2: 501-7.
54. Brown JH, Jardetzky T, Saper MA, Samraoui B, Bjorkman PJ, Wiley DC. A hypothetical model of the foreign antigen binding site of class II histocompatibility molecules. Nature 1988; 332: 845-50.
55. Kwok WW, Domeier ME, Raymond FC, Byers P, Nepom GT. Allele-specific motifs characterize HLA-DQ interactions with a diabetes-associated peptide derived from glutamic acid decarboxylase. J Immunol 1996; 156: 2171-7.
56. Ettinger RA, Kwok WW. A peptide binding motif for HLADQA1*0102/ DQB1*0602, the class II MHC molecule associated with dominant protection in insulin-dependent diabetes mellitus. J Immunol 1998; 160: 2365-73.
57. Dessen A, Lawrence CM, Cupo S, Zaller DM, Wiley DC. X ray crystal structure of HLA-DR4 (DRA*0101, DRBI*0401) complexed with a peptide from human collagen II. Immunity 1997; 7: 473-81.
58. Jaini R, Kaur G, Mehra NK. Heterogeneity of HLADRB1*04 and its associated haplotypes in the north Indian population.Hum Immunol 2002; 63: 24-9.
59. Awata T, Kuzuya T, Matsuda A, Iwamoto Y, Kanazawa Y, Okuyama M, et al. High frequency of aspartic acid at position 57 of HLA-DQbchain in Japanese IDDM patients and non-diabetic subjects. Diabetes 1990; 39: 266-9.
60. Stern LJ, Brown JH, Jardetzky TS, Gorga JC, Urban RG, Strominger JL, et al. Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide. Nature 1994; 368: 215-21.
61. Kwok WW, Domeier ME, Johnson ML, Nepom GT, Koelle DM. HLA-DQB1 codon 57 is critical for peptide binding and recognition. J Exp Med 1996; 183: 1253-8.
62. Quarsten H, Paulsen G, Johansen BH, Thorpe CJ, Holm A, Buus S, et al. The P9 pocket of HLA-DQ2 (non-Aspbeta57) has no particular preference for negatively charged anchor residues found in other type 1 diabetes-predisposing nonAsp beta57 MHC class II molecules. Int Immunol 1998; 10: 1229-36.
63. Sato AK, Sturniolo T, Sinigaglia F, Stern LJ. Substitution of aspartic acid at β57 with alanine alters MHC class II peptide binding activity but not protein stability: HLADQ(a1*0201, β1*0302) and (a1*0201, β1*0303). Hum Immunol 1999; 60: 1227-36.
64. Kelly MA, Rayner ML, Mijovic CH, Barnett AH. Molecular aspects of type 1 diabetes. Mol Pathol 2003; 56: 1-10.
65. Ettinger RA, Liu AW, Nepom GT, Kwok WW. β57-Asp plays an essential role in the unique SDS stability of HLA-DQA1*0102/DQB1*0602 αβ protein dimer, the class II MHC allele associated with protection from insulin-dependent diabetes mellitus. J Immunol 2000; 165: 3232-8.
66. Hashimoto M, Nakamura N, Obayashi H, Kimura F, Moriwaki A, Hasegawa G, et al. Genetic contribution of the BAT2 gene microsatellite polymorphism to the age-at-onset of insulin-dependent diabetes mellitus. Hum Genet 1999; 105: 197-9.
67. Shtauvere-Brameus A, Dabadghao P, Rumba I, Sanjeevi C.B. Tumor necrosis factor-a allele 2 shown an association With insulin-dependent diabetes mellitus in Latvians. Ann NY Acad Sci 2002; 958: 357-61
68. Valdes AM, Wapelhorst B, Concannon P, Erlich HA, Thomson G, Noble JA. Extended DR3-D6S273-HLA-B haplotypes are associated with increased susceptibility to type 1 diabetes in US Caucasians. Tissue Antigens 2005; 65: 115-9.
69. Koeleman BV, De Groot KN, Van Der Slik AR, Roep BO, Giphart MJ. Association between D6S2223 and type I diabetes independent of HLA class II in Dutch families. Diabetologia 2002; 45: 598-9.
70. Bahram S, Bresnahn M, Geraghty DE, Spies T.A second lineage of mammalian major histocompatibility complex class I genes. Proc Natl Acad Sci USA 1994; 91: 6259-63.
71. Bahram S, Spies T. The MIC gene family. Res Immunol 1996; 147: 328-33.
72. Ota M, Katsuyama Y, Mizuki N, Ando H, Furihata K, Ono S, et al. Trinucleotide repeat polymorphism within exon 5 of the MICA gene (MHC class I chain-related gene A): allele frequency data in the nine population groups Japanes, Northern Han. Hui, Uygur, Kagakhstan, Iranian, Saudi Arabian, Greek and Italian. Tissue Antigens 1997; 49: 448-54.
73. Nikitina Zake L, Ghaderi M, Park YS, Babu S, Eisenberth D, Sanjeevi B. MHC class I chain-related gene alleles 5 and 5.1 are transmitted more frequently to type 1 diabetes offspring in HBDI families. Ann NY Acad Sci 2002; 958: 309-11.
74. Bain SC, Prins JB, Hearne CM, Rodrigues NR, Rowe BR, Pritchard LE, et al. Insulin gene region-encoded susceptibility to type 1 diabetes is not restricted to HLA-DR4-positive individuals. Nat Genet 1992; 2: 212-5.
75. Lucassen AM, Julier C, Beressi JP, Boitard C, Froguel P, Lathrop M, et al. Susceptibility to insulin dependent diabetes mellitus maps to a 4.1kb segment of DNA spanning the insulin gene and associated VNTR. Nat Genet 1993; 4: 305-10.
76. Bennett ST, Lucassen AM, Gough SC, Powell EE, Undlien DE, Pritchard LE, et al. Susceptibility to human type 1 diabetes at IDDM2 is determined by tandem repeat variation at the insulin gene minisatellite locus. Nat Genet 1995; 9: 284-92.
77. Anjos S, Polychronakos C. Mechanism of genetic susceptibility to type 1 diabetes: beyond HLA. Mol Gen Metab 2004; 81: 187-95.
78. Stead JD, Buard J, Todd JA, Jeffreys AJ. Influence of allele lineage on the role of the insulin minisatellite in susceptibility to type 1 diabetes. Hum Mol Genet 2000; 9: 2929-35.
79. Jolicoeur C, Hanahan D, Smith KM. T-cell tolerance toward a transgenic beta-cell antigen and transcription of endogenous pancreatic genes in thymus. Proc Natl Acad Sci USA 1994; 9: 16707-11.
80. Vafiadis P, Bennett ST, Todd JA, Nadeau J, Grabs R, Goodyer CG, et al. Insulin expression in human thymus is modulated by INS VNTR alleles at the IDDM2 locus. Nat Genet 1997; 15: 289-92.
81. Pugliese A, Zeller M, Fernandez Jr A, Zalcberg LJ, Bartlett RJ, Ricordi C, et al. The insulin gene is transcribed in the human thymus and transcription levels correlated with allelic variation at the INS VNTR-IDDM2 susceptibility locus for type 1 diabetes. Nat Genet 1997; 15: 293-7.
82. Vafiadis P, Grabs R, Goodyer CG, Colle E, Polychronakos C. A functional analysis of the role of IGF2 in IDDM2-encoded susceptibility to type 1 diabetes. Diabetes 1998; 47: 831-6.
83. Vafiadis P, Bennett ST, Todd JA, Grabs R, Polychronakos C. Divergence between genetic determinants of IGF2 transcription levels in leukocytes and of IDDM2-encoded susceptibility to type 1 diabetes. J Clin Endocrinol Metab 1998; 83: 2933-9.
84. Paquette J, Giannoukakis N, Polychronakos C, Vafiadis P, Deal C. The INS 5′ variable number of tandem repeats is associated with IGF2 expression in humans. J Biol Chem 1998; 273: 14158-64.
85. Dahlquist G, Bennich SS, Kallen B. Intrauterine growth pattern and risk of childhood onset insulin dependent (type 1) diabetes: population based case-control study. BMJ 1996; 313: 1174-7.
86. Copeman JB, Cucca F, Hearne CM, Cornall RJ, Reed PW, Ronningen KS, et al. Linkage disequilibrium mapping of a type 1 diabetes susceptibility gene (IDDM7) to chromosome 2q31-q33. Nat Genet 1995; 9: 80-5.
87. Nistico L, Buzzetti R, Pritchard LE, Van Der Auwera B, Giovannini C, Bosi E, et al. The CTLA-4 gene region of chromosome 2q33 is linked to, and associated with, type 1 diabetes. Belgian Diabetes Registry. Hum Mol Genet 1996; 5: 1075-80.
88. Morahan G, Huang D, Tait BD, Colman PG, Harrison LC. Markers on distal chromosome 2q linked to insulindependent diabetes mellitus. Science 1996; 272: 1811-3.
89. Ueda H, Howson JM, Esposito L, Heward J, Snook H, Chamberlain G, et al. Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 2003; 423: 506-11.
90. Larsen ZM, Kristiansen OP, Mato E, Johannesen J, Puig-Domingo M, de Leiva A, et al. IDDM12 (CTLA4) on 2q33 and IDDM13 on 2q34 in genetic susceptibility to type 1 diabetes (insulin-dependent). Autoimmunity 1999; 31: 35-42.
91. Magistrelli G, Jeannin P, Herbault N, Benoit De Coignac A, Gauchat JF, Bonnefoy JY, et al. A soluble form of CTLA-4 generated by alternative splicing is expressed by nonstimulated human T cells. Eur J Immunol 1999; 29: 3596-602.
92. Ling V, Wu PW, Finnerty HF, Agostino MJ, Graham JR, Chen S, et al. Assembly and annotation of human chromosome 2q33 sequence containing the CD28, CTLA4, and ICOS gene cluster: analysis by computational, comparative, and microarray approaches. Genomics 2001; 78: 155-68.
93. Marron MP, Raffel LJ, Garchon HJ, Jacob CO, Serrano-Rios M, Martinez Larrad MT, et al. Insulin-dependent diabetes mellitus (IDDM) is associated with CTLA4 polymorphisms in multiple ethnic groups. Hum Mol Genet 1997; 6: 1275-82.
94. Kouki T, Sawai Y, Gardine CA, Fisfalen ME, Alegre ML, Degroot LJ. CTLA-4 gene polymorphism at position 49 in exon1 reduces the inhibitory function of CTLA-4 and contributes to the pathogenesis of Grave's disease. J Immunol 2000; 165: 6606-11.
95. Maurer M, Loserth S, Kolb-Maurer A, Ponath A, Wiese S, Kruse N, et al. A polymorphism in the human cytotoxic T lymphocyte antigen 4 ( CTLA4) gene (exon 1 +49) alters T-cell activation. Immunogenetics 2002; 54: 1-8.
96. Anjos S, Nguyen A, Qunissi-Benkalha H, Tessier MC, Polychronakos C. A common autoimmunity predisposing signal peptide variant of the cytotoxic T-lymphocyte antigen 4 results in inefficient glycosylation of the susceptibility allele. J Biol Chem 2002; 277: 46478-86.
97. Merriman T, Twells R, Merriman M, Eaves I, Cox R, Cucca F, et al. Evidence by allelic association-dependent methods for a type 1 diabetes polygene (IDDM6) on chromosome 18q21. Hum Mol Genet 1997; 6: 1003-10.
98. Copeman JB, Cucca F, Hearne CM, Cornall RJ, Reed PW, Ronningen KS, et al. Linkage disequilibrium mapping of a type 1 diabetes susceptibility gene (IDDM7) to chromosome 2q31-q33. Nat Genet 1995; 9: 80-5.
99. Reed P, Cucca F, Jenkins S, Merriman M, Wilson A, McKinney P, et al. Evidence for a type 1 diabetes susceptibility locus (IDDM10) on human chromosome 10p11-q11. Hum Mol Genet 1997; 6: 1011-6.
100. Fu J, Ikegami H, Kawaguchi Y, Fujisawa T, Kawabata Y, Hamada Y, et al. Association of distal chromosome 2q With IDDM in Japanese subjects. Diabetologia 1998; 41: 228-32.
101. Eckenrode S, Marron MP, Nicholls R, Yang MC, Yang JJ, Guida Fonseca LC, et al. Fine-mapping of the type 1 diabetes locus (IDDM4) on chromosome 11q and evaluation of two candidate genes (FADD and GALN) by affected sibpair and linkage-disequilibrium analyses. Hum Genet 2000; 106: 14-8.
102. Iwata I, Nagafuchi S, Nakashima H, Kondo S, Koga T, Yokogawa Y, et al. Association of polymorphism in the NeuroD/BETA2 gene with type 1 diabetes in the Japanese. Diabetes 1999; 48: 416-9.
103. Hansen L, Jensen JN, Urioste S, Petersen HV, Pociot F, Eiberg F, et al. NeuroD/BETA2 gene variability and diabetes: no associations to late-onset type 2 diabetes but an A45 allele may represent a susceptibility marker for type 1 diabetes among Danes. Diabetes 2000; 49: 876-8.
104. Dupont S, Dina C, Hani EH, Froguel P. Absence of replication in the French population of the association between beta2/NEUROD-A45T polymorphism and type 1 diabetes. Diabetes Metab 1999; 25: 516-7.
105. Searle S, Blackwell JM. Evidence for a functional repeat polymorphism in the promoter of the human NRAMP1 gene that correlates with autoimmune versus infectious disease susceptibility. J Med Genet 1999; 36: 295-9.
106. Bassuny WM, Ihara K, Matsuura N, Ahmed S, Kohno H, Kuromaru R, et al. Association study of NRAMP1 gene promoter polymorphism and early onset type 1 diabetes. Immunogenetics 2002: 54: 282-5.
107. Esposito L, Hill NJ, Pritchard LE, Cucca F, Muxworthy C, Merriman ME, et al. Genetic analysis of chromosome 2 in type 1 diabetes: analysis of putative loci IDDM7, IDDM12, and IDDM13 and candidate genes NRAMP1 and IA-2 and interleukin- 1 gene cluster. IMDIAB Group. Diabetes 1998; 47: 1797-9.
108. Dustin ML, Rothlein R, Bhan AK, Dinarello CA, Springer TA. Induction by IL1 and interferon-gamma: tissue distribution, biochemistry, function of a natural adherence molecule (ICAM-1). J Immunol 1986; 137: 245-54.
109. Springer TA. Adhesion receptors of the immune system. Nature 1990; 346: 425-34.
110. Yagi N, Yokono K, Amano K, Nagata M, Tsukamoto K, Hasegawa Y, et al. Expression of intercellular adhesion molecule 1 on pancreatic β-cells accelerates β-cell destruction by cytotoxic T-cells in murine autoimmune diabetes. Diabetes 1995; 44: 744-52.
111. Vora DK, Rosenbloom CL, Beaudet AL, Cottingham RW. Polymorphisms and linkage analysis for ICAM-1 and the selectin gene cluster. Genomics 1994; 21: 473-7.
112. Masataka N, Hiroshi O, Etsuko M, Mitsuhiro O, Hisataka T, Michiaki F, et al. Association between type 1 diabetes age-at-onset and intercellular adhesion molecule-1 (ICAM-1) gene polymorphism. Hum Immunol 2000; 61: 507-10.
113. Hill RJ, Zozulya S, Lu YL, Ward K, Gishizky M, Jallal B. The lymphoid protein tyrosine phosphatase Lyp interacts with the adaptor molecule Grb2 and functions as a negative regulator of T-cell activation. Exp Hematol 2002; 30: 237-44.
114. Bottini N, Musumeci L, Alonso A, Rahmouni S, Nika K, Rostamkhani M, et al. A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes. Nat Genet 2004; 36: 337-8.
115. Ladner MB, Bottini N, Valdes AM, Noble JA. Association of the single nucleotide polymorphism C1858T of the PTPN22 gene with type 1 diabetes. Hum Immunol 2005; 66: 60-4.
116. McAllister LB, Jeffery DA, Lee AT, Batliwalla F, Remmers E, Criswell LA, et al. A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis. Am J Hum Genet 2004; 75: 330-7.
117. Kyogoku C, Langefeld CD, Ortmann WA, Lee A, Selby S, Carlton VE, et al. Genetic association of the R620W polymorphism of protein tyrosine phosphatase PTPN22 with human SLE. Am J Hum Genet 2004; 75: 504-7.
118. Clark LB, Appleby MW, Brunkow ME, Wilkinson JE, Ziegler SF, Ramsdell F. Cellular and molecular characterization of the scurfy mouse mutant. J Immunol 1999; 162: 2546-54.
119. Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 2003; 299: 1057-61.
120. Von Herrath MG, Harrison LC. Antigen-induced regulatory T cells in autoimmunity. Nat Rev Immunol 2003; 3: 223-32.
121. Shevach EM. Regulatory T cells in autoimmmunity. Annu Rev Immunol 2000; 18: 423-49.
122. Bennett CL, Christie J, Ramsdell F, Brunkow ME, Ferguson PJ, Whitesell L, et al. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat Genet 2001; 27: 20-1.
123. Bassuny WM, Ihara K, Sasald Y, Kuromaru R, Kohno H, Matsuura N, et al. A functional polymorphism in the promoter/enhancer region of the FOXP3/Scurfin gene associated with type 1 diabetes. Immunogenetics 2003; 55: 149-56.
124. Zavattari P, Deidda E, Pitzalis M, Zoa B, Moi L, Lampis R, et al. No association between variation of the FOXP3 gene and common type 1 diabetes in the Sardinian population. Diabetes 2004; 53: 1911-4.
125. Sanchez E, Rueda B, Orozco G, Oliver J, Vilchez JR, Paco L, et al. Analysis of a GT microsatellite in the promoter of the foxp3/ scurfin gene in autoimmune diseases. Hum Immunol 2005; 66: 869-73.